DK0414422T3 - 2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater deraf - Google Patents
2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater derafInfo
- Publication number
- DK0414422T3 DK0414422T3 DK90308785.6T DK90308785T DK0414422T3 DK 0414422 T3 DK0414422 T3 DK 0414422T3 DK 90308785 T DK90308785 T DK 90308785T DK 0414422 T3 DK0414422 T3 DK 0414422T3
- Authority
- DK
- Denmark
- Prior art keywords
- group
- azaspiro
- oxa
- oxo
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU894093A HU204529B (en) | 1989-08-10 | 1989-08-10 | Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0414422T3 true DK0414422T3 (da) | 1994-05-16 |
Family
ID=10966862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90308785.6T DK0414422T3 (da) | 1989-08-10 | 1990-08-09 | 2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater deraf |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0414422B1 (es) |
JP (1) | JPH0377885A (es) |
KR (1) | KR950001022B1 (es) |
AT (1) | ATE103921T1 (es) |
AU (1) | AU623545B2 (es) |
DD (1) | DD299427A5 (es) |
DE (1) | DE69007905T2 (es) |
DK (1) | DK0414422T3 (es) |
ES (1) | ES2052181T3 (es) |
HU (1) | HU204529B (es) |
IL (1) | IL95321A (es) |
NZ (1) | NZ234845A (es) |
ZA (1) | ZA906301B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR940003491B1 (ko) * | 1989-08-10 | 1994-04-23 | 리히터 게데온 베기에스제티 기아르 알.티 | 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물 |
HU204530B (en) * | 1989-08-10 | 1992-01-28 | Richter Gedeon Vegyeszet | Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them |
HU204054B (en) * | 1989-08-10 | 1991-11-28 | Richter Gedeon Vegyeszet | Process for producing new 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions comprising same |
YU150489A (sh) * | 1989-08-10 | 1992-12-21 | W.L. Gore & Co. Gmbh. | Uređaj za ispitivanje odevnih predmeta na nepromočivost |
FR2691459B1 (fr) * | 1992-05-25 | 1995-06-09 | Adir | Nouveaux derives de la phenothiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
ATE329579T1 (de) | 1999-11-12 | 2006-07-15 | Abbott Lab | Feste dispersion mit ritonavir, fenofibrat oder griseofulvin |
DE10026698A1 (de) | 2000-05-30 | 2001-12-06 | Basf Ag | Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung |
US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
BRPI0414696A (pt) | 2003-09-26 | 2006-11-28 | Sony Computer Entertainment Inc | dispositivo eletrÈnico portátil |
BRPI0507586A (pt) * | 2004-02-10 | 2007-07-03 | Hoffmann La Roche | moduladores de receptor de quimiocina ccr5 |
AU2008233930A1 (en) | 2007-03-29 | 2008-10-09 | F. Hoffmann-La Roche Ag | Heterocyclic antiviral compounds |
CA3094481A1 (en) | 2018-04-06 | 2019-10-10 | Camp4 Therapeutics Corporation | Phenothiazine derivatives and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1256404A (en) * | 1968-06-07 | 1971-12-08 | Dainippon Pharmaceutical Co | 0-oxa-3,8-diazaspiro(4,5)decan-2,4-diones |
DE2118339A1 (de) * | 1971-04-15 | 1972-10-26 | Yoshitomi Pharmaceutical Industries Ltd, Osaka (Japan) | Pipendinspiroverbindungen |
US4255432A (en) * | 1979-09-06 | 1981-03-10 | Syntex (U.S.A.) Inc. | 8-[2-3-Indolyl)ethyl]-1-oxa-3-,8-diazaspiro[4.5]decan-2-ones, pharmaceutical compositions thereof and methods of use thereof |
FR2615515B1 (fr) * | 1987-05-22 | 1989-06-30 | Adir | Nouveaux derives du spiro 4, 5 decane, leur procede de preparation et les compositions pharmaceutiques les renfermant |
YU150489A (sh) * | 1989-08-10 | 1992-12-21 | W.L. Gore & Co. Gmbh. | Uređaj za ispitivanje odevnih predmeta na nepromočivost |
-
1989
- 1989-08-10 HU HU894093A patent/HU204529B/hu not_active IP Right Cessation
-
1990
- 1990-08-09 ZA ZA906301A patent/ZA906301B/xx unknown
- 1990-08-09 ES ES90308785T patent/ES2052181T3/es not_active Expired - Lifetime
- 1990-08-09 DE DE69007905T patent/DE69007905T2/de not_active Expired - Fee Related
- 1990-08-09 DD DD90343353A patent/DD299427A5/de not_active IP Right Cessation
- 1990-08-09 IL IL9532190A patent/IL95321A/en not_active IP Right Cessation
- 1990-08-09 JP JP2209359A patent/JPH0377885A/ja active Pending
- 1990-08-09 AU AU60802/90A patent/AU623545B2/en not_active Ceased
- 1990-08-09 KR KR1019900012255A patent/KR950001022B1/ko active IP Right Grant
- 1990-08-09 NZ NZ234845A patent/NZ234845A/en unknown
- 1990-08-09 DK DK90308785.6T patent/DK0414422T3/da active
- 1990-08-09 AT AT90308785T patent/ATE103921T1/de not_active IP Right Cessation
- 1990-08-09 EP EP90308785A patent/EP0414422B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0414422A2 (en) | 1991-02-27 |
ATE103921T1 (de) | 1994-04-15 |
DE69007905D1 (de) | 1994-05-11 |
HU204529B (en) | 1992-01-28 |
JPH0377885A (ja) | 1991-04-03 |
IL95321A (en) | 1994-02-27 |
AU623545B2 (en) | 1992-05-14 |
ES2052181T3 (es) | 1994-07-01 |
KR910004633A (ko) | 1991-03-29 |
ZA906301B (en) | 1991-06-26 |
HUT55784A (en) | 1991-06-28 |
EP0414422B1 (en) | 1994-04-06 |
AU6080290A (en) | 1991-02-14 |
DE69007905T2 (de) | 1994-07-21 |
KR950001022B1 (ko) | 1995-02-07 |
DD299427A5 (de) | 1992-04-16 |
NZ234845A (en) | 1992-03-26 |
IL95321A0 (en) | 1991-06-30 |
EP0414422A3 (en) | 1991-07-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0414422T3 (da) | 2-Oxo-1-oxa-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt præparater deraf | |
EP0385446A3 (en) | Osteogenesis promotion with use of vitamin d derivatives | |
DK0414421T3 (da) | 1-Oxa-2-oxo-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt farmaceutiske præparater med indhold deraf | |
FI903973A0 (fi) | Nya 2-oxo-1-oxa-8-azaspiro/4,5/ dekanderivat, farmaceutiska kompositioner innehaollande dessa och foerfarande foer framstaellning av dessa. | |
FI903511A0 (fi) | Pyrrolo (2,1-b) tiazolderivat. |